Motley Fool |
Big News Sends Tandem Diabetes Soaring 10.2% Today
Motley Fool For this reason, the approval of Tandem Diabetes Care's latest upgrade to its insulin pumps is important. In trials, using Tandem's Basal-IQ algorithm to predict blood sugar levels 30 minutes into the future resulted in a 31% relative reduction in time ... Oppenheimer updates on Tandem Diabetes Care Tandem Diabetes Stock Shorts Crushed on FDA Approval Tandem Diabetes Rallies After FDA Approves Insulin Pump With New Technology |
from diabetes - Google News
Social Plugin